At present, few studies have focused on the molecular neuropathologic correlation of glioma with tumor-related epilepsy [11], except for several studies on the association between WHO classification and IDH1 mutation in brain tumor-related epilepsy of patients with low-grade glioma [25, 34, 35]. Here, IDH1 is linked to central nervous system cancer.